MENU
Exelixis (EXEL) Ownership - Who owns Exelixis?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.5B
P/E Ratio
22.68
Total Cash
1B
Projected Growth
2.22
Total Debt
198.02M
Revenue
2.01B
Risk (Beta)
0.42
Dividend Yield
N/A
Total Cash/Share
3.51
Total Debt/Equity
479.87
Revenue/Share
6.54 USD as % of share price
Fundamentals
EXEL
Capitalization
7.51B
P/E Ratio
22.68
Risk (Beta)
0.42
Dividend Yield
N/A
Total Cash
1B
Total Cash/Share
3.51
Total Debt
198M
Total Debt/Equity
479.87
Projected Growth (PEG Ratio)
2.22
Revenue/Share (as % of the share price)
6.54%
Revenue
2.01B
ROE
N/A
Book Value
2.12B
P/B Ratio
3.54
Cash Flow
N/A
Earnings
1.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
285K
Current Ratio
4.27
Current Revenue Per Employee
486395.40
Dividends Per Share - Security
N/A
EBITDA
429M
Float
N/A
Float - Current
N/A
Gross Income Margin
97.23
Revenue To Assets
11.83
Shares Held By Institutions
11.7B
Shares Outstanding - Current
285M
Total Liabilities
653M
Total Volume MTD
N/A
Value
-1
Gain YTD
9.671
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of small molecule therapies for the treatment of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com